Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Actavis Inc       US9426831031

SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Watson Pharmaceuticals, Inc. : Watson to Present at the Bank of America Merrill Lynch 2012 Health Care Conference

05/04/2012 | 04:05pm US/Eastern
Recommend:
0

PARSIPPANY, N.J., May 4, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty global pharmaceutical company, announced today that Paul Bisaro, Watson's President and Chief Executive Officer, will provide an overview and update of the Company's business at the Bank of America Merrill Lynch 2012 Healthcare Conference on Wednesday, May 16, 2012 at 10:00 AM Pacific Time at the Encore at the Wynn in Las Vegas, Nevada. The presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at http://ir.watson.com. The webcast can also be accessed at the following URL: http://www.veracast.com/webcasts/baml/healthcare2012/id16635640.cfm

An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. The Company is also developing biosimilar products in Women's Health and Oncology. Additionally, Watson distributes generic and branded pharmaceuticals through its Anda, Inc. distribution business. Watson has operations in many of the worlds established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

    CONTACTS:                         Investors:
                                      Lisa DeFrancesco
                                      (862) 261-7152

                                      Media:
                                      Charlie Mayr
                                      (862) 261-8030

(Photo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO)

SOURCE Watson Pharmaceuticals, Inc.

Recommend :
0
React to this article
Latest news on ACTAVIS INC
1h ago ACTAVIS : to Host Third Quarter 2014 Earnings Conference Call and Webcast
1d agoDJAllergan Reiterates Opposition to Valeant Bid
5d ago ACTAVIS : Confirms Generic Butrans® Patent Challenge
6d agoDJDOW INDEX OVERSEERS MAKE IT OFFICIAL : U.S. Firms Only
6d ago ACTAVIS IN BUYOUT TALKS WITH SALIX : Cnbc
6d agoDJU.S. HOT STOCKS : Hot Stocks to Watch
7d ago Pfizer approaches Actavis to gauge interest in deal - Bloomberg
7d agoDJPfizer Has Contacted Actavis About Potential Deal, Parties Not In Formal Talk..
09/16DJU.S. HOT STOCKS : Hot Stocks to Watch
09/09 ACTAVIS : FDA Advisory Committee Recommends Against Approval of Actavis' Nebivol..
Dynamic quotes  
ON
| OFF